| Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients S Jarius, K Ruprecht, B Wildemann, T Kuempfel, M Ringelstein, C Geis, ... Journal of neuroinflammation 9, 1-17, 2012 | 817 | 2012 |
| Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses I Kleiter, A Gahlen, N Borisow, K Fischer, KD Wernecke, B Wegner, ... Annals of neurology 79 (2), 206-216, 2016 | 387 | 2016 |
| Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures S Jarius, F Paul, D Franciotta, K Ruprecht, M Ringelstein, R Bergamaschi, ... Journal of the neurological sciences 306 (1-2), 82-90, 2011 | 377 | 2011 |
| Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance S Jarius, D Franciotta, F Paul, K Ruprecht, R Bergamaschi, PS Rommer, ... Journal of neuroinflammation 7, 1-8, 2010 | 214 | 2010 |
| Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis S Jarius, J Frederikson, P Waters, F Paul, G Akman-Demir, R Marignier, ... Journal of the neurological sciences 298 (1-2), 158-162, 2010 | 187 | 2010 |
| Longitudinal extensive transverse myelitis—it's not all neuromyelitis optica C Trebst, P Raab, EV Voss, P Rommer, M Abu-Mugheisib, UK Zettl, ... Nature Reviews Neurology 7 (12), 688-698, 2011 | 186 | 2011 |
| Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders S Jarius, C Jacobi, J de Seze, H Zephir, F Paul, D Franciotta, P Rommer, ... Multiple Sclerosis Journal 17 (9), 1067-1073, 2011 | 181 | 2011 |
| CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Review of an increasingly recognized entity within the spectrum of … A Dudesek, F Rimmele, S Tesar, S Kolbaske, PS Rommer, R Benecke, ... Clinical & Experimental Immunology 175 (3), 385-396, 2014 | 165 | 2014 |
| Immunological aspects of approved MS therapeutics PS Rommer, R Milo, MH Han, S Satyanarayan, J Sellner, L Hauer, Z Illes, ... Frontiers in immunology 10, 1564, 2019 | 149 | 2019 |
| Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI A Dal-Bianco, G Grabner, C Kronnerwetter, M Weber, B Kornek, ... Brain 144 (3), 833-847, 2021 | 144 | 2021 |
| Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry PS Rommer, K Eichstädt, D Ellenberger, P Flachenecker, T Friede, ... Multiple Sclerosis Journal 25 (12), 1641-1652, 2019 | 138 | 2019 |
| Requirement for safety monitoring for approved multiple sclerosis therapies: an overview PS Rommer, UK Zettl, B Kieseier, HP Hartung, T Menge, E Frohman, ... Clinical & Experimental Immunology 175 (3), 397-407, 2014 | 103 | 2014 |
| Managing the side effects of multiple sclerosis therapy: pharmacotherapy options for patients PS Rommer, UK Zettl Expert opinion on pharmacotherapy 19 (5), 483-498, 2018 | 96 | 2018 |
| Vaccination in multiple sclerosis: friend or foe? T Zrzavy, H Kollaritsch, PS Rommer, N Boxberger, M Loebermann, ... Frontiers in Immunology 10, 1883, 2019 | 88 | 2019 |
| Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry S Jarius, D Franciotta, F Paul, R Bergamaschi, PS Rommer, K Ruprecht, ... Journal of the neurological sciences 320 (1-2), 32-37, 2012 | 88 | 2012 |
| The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy–A prospective, pilot observational study J Ehler, A Petzold, M Wittstock, S Kolbaske, M Gloger, J Henschel, ... PLoS One 14 (1), e0211184, 2019 | 77 | 2019 |
| Interleukin-6 receptor blockade in treatment-refractory MOG-IgG–associated disease and neuromyelitis optica spectrum disorders M Ringelstein, I Ayzenberg, G Lindenblatt, K Fischer, A Gahlen, G Novi, ... Neurology: Neuroimmunology & Neuroinflammation 9 (1), e1100, 2021 | 75 | 2021 |
| Detection methods for autoantibodies in suspected autoimmune encephalitis G Ricken, C Schwaiger, D De Simoni, V Pichler, J Lang, S Glatter, ... Frontiers in neurology 9, 841, 2018 | 74 | 2018 |
| Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis UK Zettl, P Rommer, P Hipp, R Patejdl Therapeutic advances in neurological disorders 9 (1), 9-30, 2016 | 74 | 2016 |
| Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS B Zeka, M Hastermann, S Hochmeister, N Kögl, N Kaufmann, K Schanda, ... Acta neuropathologica 130, 783-798, 2015 | 72 | 2015 |
